Takeda to build $106M vaccine plant for dengue vax push

2 Dec

fiercepharma.com 30 Nov, 2016

Japan’s Takeda will build a plant for dengue vaccine at its manufacturing site in Singen, Germany. Construction will begin shortly on the $106 million project and is slated to be complete in 2019.

Leave a Reply

Your email address will not be published. Required fields are marked *